1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Study protocol of the InterVitaminK trial : A Danish population-based randomised double-blinded placebo-controlled trial of the effects of vitamin K (menaquinone-7) supplementation on cardiovascular, metabolic and bone health
(
- Contribution to journal › Article
- 2016
-
Mark
Increased risk of male cancer and identification of a potential prostate cancer cluster region in BRCA2.
(
- Contribution to journal › Article
-
Mark
No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families.
(
- Contribution to journal › Article
-
Mark
BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population.
(
- Contribution to journal › Article